Logo

Qiagen EZ2 Connect MDx

Jan 19, 2023

Qiagen has launched the EZ2 Connect MDx system for clinical use. The automated sample processing system was previously available for research use. It uses pre-filled, sealed reagent cartridges and bead-based technology to purify RNA and DNA from blood plasma, serum, stool, or other sample types. The system can process 24 samples in parallel in approximately 30 minutes. It can be used in research mode or in a dedicated IVD mode and can access the QIAsphere digital laboratory ecosystem, which enables full integration into the digital infrastructure of a lab and remote instrument management. EZ2 Connect MDx is CE-IVD marked and available in the US, Canada, and other countries.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.